Plus Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 07/14/2023 | 1.09 M | $316,956 | 0.00% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 05/12/2023 | 264,310 | $77,000 | 237.26% | 0.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 255,148 | $73,993 | -1.13% | 0.05% |
| BLACKROCK INC. | 05/12/2023 | 104,427 | $30,284 | 0.00% | 0.02% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2023 | 69,669 | $20,000 | -49.11% | 0.01% |
| NORTHERN TRUST CORP | 05/15/2023 | 57,581 | $16,698 | 79.44% | 0.01% |
| STATE STREET CORP | 05/15/2023 | 34,414 | $9,980 | 0.00% | 0.01% |
| GREAT VALLEY ADVISOR GROUP, INC. | 05/03/2023 | 33,600 | $9,744 | 0.00% | 0.01% |
| CREATIVE PLANNING | 05/15/2023 | 33,540 | $9,727 | 0.00% | 0.01% |
| TWO SIGMA ADVISERS, LP | 05/15/2023 | 32,100 | $9,309 | -2.13% | 0.01% |
| TWO SIGMA SECURITIES, LLC | 05/15/2023 | 23,449 | $6,800 | -42.45% | 0.00% |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 04/23/2024 | 12,230 | $3,547 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/09/2023 | 9,056 | $3,000 | -0.37% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2023 | 2,003 | $580 | 0.00% | 0.00% |
| FMR LLC | 08/11/2023 | 2,000 | $580 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 234 | $68 | 1.74% | 0.00% |
| UMB BANK, N.A. | 04/11/2023 | 54 | $16 | 100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/12/2023 | 21 | $6 | 0.00% | 0.00% |
| UBS GROUP AG | 05/12/2023 | 13 | $4 | -99.93% | 0.00% |
| MORGAN STANLEY | 05/15/2023 | 10 | $3 | 400.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 04/18/2023 | 1 | $1 | 100.00% | 0.00% |
| BARCLAYS PLC | 05/04/2023 | 1 | $0 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2023 | 1 | $0 | 0.00% | 0.00% |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | 04/13/2023 | 1 | $0 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/18/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| B. RILEY WEALTH ADVISORS, INC. | 05/17/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/01/2023 | 0 | $0 | -100.00% | 0.00% |
| WARBERG ASSET MANAGEMENT LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
Plus Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Plus Therapeutics, Inc.. The most heavily invested institutionals were:
LADENBURG THALMANN FINANCIAL SERVICES INC.: 9
Advisor Group, Inc.: 1
0.39% of Plus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10 shares in the last 24 months. This purchase volume represents approximately $11 in transactions.